Literature DB >> 22039269

Treatment of trigger finger: randomized clinical trial comparing the methods of corticosteroid injection, percutaneous release and open surgery.

Edson S Sato1, João B Gomes Dos Santos, João C Belloti, Walter M Albertoni, Flavio Faloppa.   

Abstract

OBJECTIVE: The aim of this study is to evaluate the effectiveness of CS injection, percutaneous pulley release and conventional open surgery for treating trigger finger in terms of cure, relapse and complication rates.
METHODS: One hundred and thirty-seven patients with a total of 150 fingers were randomly assigned and allocated into one of the treatment groups, with treatments allocated into 150 opaque and sealed envelopes. We included patients >15 years of age with a trigger on any finger of the hand (Types II-IV) and used a minimum follow-up time of 6 months. The primary outcome measures were cures, relapses and failures.
RESULTS: Forty-nine patients were assigned to the conservative group to undergo CS injections, whereas 45 and 56 were assigned to undergo percutaneous release and outpatient open surgery, respectively. The trigger cure rate for patients in the injection method group was 57%, and wherever necessary, two injections were administered, which increased the cure rate to 86%. For the percutaneous and open release methods, remission of the trigger was achieved in all cases.
CONCLUSIONS: The percutaneous and open surgery methods displayed similar effectiveness and proved superior to the conservative CS method regarding the trigger cure and relapse rates. Trial registration. Current Controlled Trials, http://www.controlled-trials.com/, ISRCTN19255926.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039269     DOI: 10.1093/rheumatology/ker315

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  24 in total

1.  Treatment preferences for trigger digit by members of the American Association for Hand Surgery.

Authors:  Jason S Pruzansky; Peter Goljan; David P Lundmark; Eon K Shin; Sidney M Jacoby; A Lee Osterman
Journal:  Hand (N Y)       Date:  2014-12

2.  A prospective randomized trial comparing the effectiveness of one versus two (staged) corticosteroid injections for the treatment of stenosing tenosynovitis.

Authors:  Emran Sheikh; John D Peters; Will Sayde; Mitchell Maltenfort; Charles Leinberry
Journal:  Hand (N Y)       Date:  2014-09

3.  How Do You Treat Trigger Finger in Your Practice?

Authors: 
Journal:  Med Acupunct       Date:  2018-08-01

4.  Characteristics and Clinical Outcomes of Open Surgery for Trigger Digits in Diabetes.

Authors:  Sean Wei Loong Ho; Ching Yee Chia; Vaikunthan Rajaratnam
Journal:  J Hand Microsurg       Date:  2018-10-01

5.  Long-Term Effectiveness of Repeat Corticosteroid Injections for Trigger Finger.

Authors:  Agnes Z Dardas; James VandenBerg; Tony Shen; Richard H Gelberman; Ryan P Calfee
Journal:  J Hand Surg Am       Date:  2017-04       Impact factor: 2.230

6.  Early Patient Satisfaction with Different Treatment Pathways for Trigger Finger and Thumb.

Authors:  Stéphanie J E Becker; Yvonne Braun; Stein J Janssen; Valentin Neuhaus; David Ring; Chaitanya S Mudgal
Journal:  J Hand Microsurg       Date:  2015-10-15

7.  Percutaneous release, open surgery, or corticosteroid injection, which is the best treatment method for trigger digits?

Authors:  Jia Wang; Jia-Guo Zhao; Cong-Cong Liang
Journal:  Clin Orthop Relat Res       Date:  2012-12-04       Impact factor: 4.176

Review 8.  Gliding resistance and modifications of gliding surface of tendon: clinical perspectives.

Authors:  Peter C Amadio
Journal:  Hand Clin       Date:  2013-03-15       Impact factor: 1.907

9.  Trigger finger.

Authors:  Edson S Sato
Journal:  N Am J Med Sci       Date:  2012-09

10.  A cadaveric assessment of percutaneous trigger finger release with 15° stab knife: its effectiveness and complications.

Authors:  Abbas Abdoli; Majid Asadian; Seyed Houssein Saeed Banadaky; Rabeah Sarram
Journal:  J Orthop Surg Res       Date:  2021-07-03       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.